|
NCAPH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.9231000000518E-06 |
| Normal-vs-Stage2 |
2.089900E-02 |
| Normal-vs-Stage3 |
1.416700E-04 |
| Normal-vs-Stage4 |
1.352010E-02 |
| Stage1-vs-Stage2 |
8.408600E-01 |
| Stage1-vs-Stage3 |
6.300700E-03 |
| Stage1-vs-Stage4 |
1.763980E-02 |
| Stage2-vs-Stage3 |
1.758150E-02 |
| Stage2-vs-Stage4 |
6.373900E-02 |
| Stage3-vs-Stage4 |
8.030600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.26392254837538E-12 |
| Normal-vs-AfricanAmerican |
1.72158999999228E-05 |
| Normal-vs-Asian |
1.184400E-01 |
| Caucasian-vs-AfricanAmerican |
2.728600E-01 |
| Caucasian-vs-Asian |
2.657800E-01 |
| AfricanAmerican-vs-Asian |
3.184000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.02424751907893E-13 |
| Normal-vs-Female |
2.64100000002543E-06 |
| Male-vs-Female |
2.351700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.04229999999961E-05 |
| Normal-vs-Extreme_Weight |
7.17490000745613E-09 |
| Normal-vs-Obese |
3.45619999997382E-06 |
| Normal-vs-Extreme_Obese |
7.699600E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.955400E-01 |
| Normal_Weight-vs-Obese |
2.772200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.637400E-03 |
| Extreme_Weight-vs-Obese |
1.847700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.366400E-02 |
| Obese-vs-Extreme_Obese |
5.599800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.922200E-03 |
| Normal-vs-Age(41-60Yrs) |
9.73020553018955E-11 |
| Normal-vs-Age(61-80Yrs) |
2.37459999996581E-06 |
| Normal-vs-Age(81-100Yrs) |
1.474070E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.278300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.380800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.061600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.656200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.063760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.141000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.92277313462819E-12 |
| Normal-VS-Type2 PRCC |
2.44440000018997E-07 |
| Normal-VS-KIRP CIMP |
5.578000E-03 |
| Normal-VS-Unclassified PRCC |
1.90473999999163E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.787600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.265860E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.971700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.475900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.534000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.209900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.96529999999728E-05 |
| Normal-vs-N1 |
2.01669999999599E-05 |
| Normal-vs-N2 |
1.301650E-01 |
| N0-vs-N1 |
5.409000E-04 |
| N0-vs-N2 |
1.192440E-01 |
| N1-vs-N2 |
3.451400E-01 |
|
|
